Gil Aharon - 25 Nov 2024 Form 3 Insider Report for Neuraxis, INC (NRXS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NRXS	Series B Convertible Preferred Stock							25 Nov 2024	Common Shares	105,042	$2.38	Direct	F1
holding	NRXS	Series B Convertible Preferred Stock							25 Nov 2024	Common Shares	1,890,756	$2.38	By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each share of Series B Convertible Preferred Stock has no expiration date and a stated value of $2.38
F2	Reporting Person disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein

Aharon Gil, Secretary of Rosalind Advisors, Inc was appointed to the Board of Directors of NeurAxis, Inc effective January 01, 2025.